ARCHIVES

In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm

This article is from The Cancer Letter archive.

Vol. 24 No. 02 | January 16, 1998

Download PDF Visit The Full Archive

Related Articles

NCI R01 Payline Falls To 12th Percentile In Fifth Year Of No-Growth Budgets.

March 7, 2008

In Brief: King ACCC President, Fleming President Elect; Wyngaarden Says He Doesn’t Oppose Panel

March 25, 1988

Emory Executive Objects to Report On Merit review

July 22, 1977

Collins Sworn In As NIH Director

September 4, 2009

Non-Profit Spent $1.3 Million On Consultants.

March 28, 2008

A Transcript: what Fisher Knew, When Did He Know

June 24, 1994